Document is current
Any future updates will be listed below
-
Authors
Fan, Yu-Ching
Fong, Yu-Cin
Kuo, Chun-Tse
Li, Chia-Wei
Chen, Wei-Yu
Lin, Jian-Da
Bürtin, Florian
Linnebacher, Michael
Bui, Quoc Thang
Lee, Kuan-Der
Tsai, Yuan-Chin https://orcid.org/0000-0003-3264-3513
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST109-2314-B-001-002-MY3, MOST 109-2314-B-0001-008-MY3, MOST 110-2314-B-038-135-MY3)
Academia Sinica (AS-KPQ-111-KNT, AS-GC-110-05)
- License Information
-
More Information
Article History
Received: 21 April 2023
Accepted: 19 July 2023
First Online: 10 August 2023
Declarations
:
: The authors declare no competing interests.
: Human pancreatic cancer tissues and sera were acquired by the approval by the Taipei Medical University-Joint Institutional Review Board (Taipei, Taiwan, approval no.: N202011039). PDXs samples were approved by the institutional review board of the University Medical Center Rostock (Rostock, Germany, approval nos.: II HV 43/2004, A 45/2007, and A 2018-0054). The syngeneic orthotopic mouse model was performed in accordance with a protocol approved by the Taipei Medical University Animal Care and Use Committee (no.: LAC-2020-0255, Taipei, Taiwan). The subcutaneous model using ASID mice (NOD.Cg-<i>Prkdc</i><sup><i>scid</i></sup><i>Il2rg</i><sup><i>tm1Wjl</i></sup>/YckNarl) was conducted with the protocol approved by the Academia Sinica (no: 19-11-1357).
: Not applicable.
